ADVANCED PROTEOME THERAPEUTICS
Cancer is a complex disease, and for therapies to be maximally effective, they must distinguish between normal and cancerous cells. Combination therapies have been employed to counter the multiple mechanisms that tumors use to evade the immune response and resist the efficacious effects of therapeutics. Despite continuing challenges, useful synergies have been obtained with a combination of individual drugs, and, as a result, a broad range of drug types are now being combined because of the promise and the compelling rationale behind combination therapy. Thus, effective treatment for cancer requires not only the discovery of individual drugs with antitumor activity, but also knowledge of the best way to combine these drugs.
ADVANCED PROTEOME THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2007-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.advancedproteome.com
Total Employee:
1+
Status:
Active
Contact:
(617)638-0340
Total Funding:
3.89 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF WordPress Google Maps SSL By Default ReCAPTCHA Organization Schema Wordpress Plugins Google Apps For Business
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Annias Immunotherapeutics
Annias Immunotherapeutics is a clinical focused on the development of novel immunotherapeutic approaches to treat cancers Cytomegalovirus.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Advisors List
Board_member
2007-01-01
Current Employees Featured
Allen Krantz President/CEO @ Advanced Proteome Therapeutics
President/CEO
Kenneth C. Phillippe Chief Financial Officer @ Advanced Proteome Therapeutics
Chief Financial Officer
Founder
Stock Details
Official Site Inspections
http://www.advancedproteome.com Semrush global rank: 10.09 M Semrush visits lastest month: 264
- Host name: rssd5382.webaccountserver.com
- IP address: 192.138.189.191
- Location: Cary United States
- Latitude: 35.7965
- Longitude: -78.7981
- Metro Code: 560
- Timezone: America/New_York
- Postal: 27513
More informations about "Advanced Proteome Therapeutics"
Our Company and Our People | Advanced Proteome
Dr. Greg Thurber. Faculty of Chemical Engineering and Biomedical Engineering at the University of Michigan. Dr. Thurber’s work involves applying fundamental biotransport principles to …See details»
Advanced Proteome Therapeutics Corporation Company Profile
Find company research, competitor information, contact details & financial data for Advanced Proteome Therapeutics Corporation of Toronto, ON. Get the latest business insights from Dun …See details»
Advanced Proteome Therapeutics - Crunchbase Company Profile …
Cancer is a complex disease, and for therapies to be maximally effective, they must distinguish between normal and cancerous cells. Combination therapies have been employed to counter …See details»
Advanced Proteome Therapeutics Incorporated | LinkedIn
Advanced Proteome Therapeutics Incorporated Biotechnology Research Boston, Massachusetts 127 followers Better, safer cancer therapeutics.See details»
Advanced Proteome Therapeutics - Overview, News & Similar
Mar 6, 2023 View Advanced Proteome Therapeutics (www.advancedproteome.com) location in British Columbia, Canada , revenue, industry and description. Find related and similar …See details»
Advanced Proteome Therapeutics, Inc. (Advanced Proteome …
May 7, 2025 Burnaby, British Columbia--(News - March 6, 2023) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company") is pleased to …See details»
Organization: Advanced Proteome Therapeutics - Cbonds.com
Organization name. Advanced Proteome Therapeutics Corporation. Country name. Canada Country of registration. Canada. Industry. Pharmaceutical Preparation and Biotechnology. …See details»
Account Suspended
What do we do? Our work allows cancer drugs to be efficiently produced, and delivered to cancerous tumors in a targeted fashion that doesn’t destroy the patient’s normal healthy cells …See details»
Advanced Proteome Therapeutics - PitchBook
Nov 4, 2017 Advanced Proteome Therapeutics General Information Description. Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a …See details»
Advanced Proteome Therapeutics and ImmunoBiochem
Feb 7, 2018 www.advancedproteome.com. FOR FURTHER INFORMATION PLEASE CONTACT: Advanced Proteome Therapeutics Corporation Dr. Randal D. Chase President …See details»
Advanced Proteome Therapeutics - Craft
Advanced Proteome Therapeutics's Chief Executive Officer, President, and Director is Bill Dickie. Other executives include Benjamin Krantz, Director; Paul Woodward, Director. See the full …See details»
Nextsource | Company Profile | Advanced Proteome Therapeutics
Explore the company profile of Advanced Proteome Therapeutics (advancedproteome.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Our Work | Advanced Proteome
Advanced Proteome Therapeutics Inc. has developed a proprietary approach for streamlining the production and targeted delivery of anti-cancer drugs to cancerous tumors.See details»
Advanced Proteome Therapeutics Corporation Announces Launch
May 3, 2017 VANCOUVER, BC--(Marketwired - May 03, 2017) - Advanced Proteome Therapeutics Corporation (See details»
News and Events | Advanced Proteome
Aug 17, 2022 Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) is pleased to announce that, further to its news release of March 11, 2021 …See details»
Advanced Proteome Therapeutics Update on Plans for 2022
Feb 3, 2022 Vancouver, British Columbia–(Newsfile Corp. – February 3, 2022) – Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) (“APC” or the “Company”), is …See details»
Advanced Proteome Therapeutics Expands Operations
Nov 23, 2021 Vancouver, British Columbia--(Newsfile Corp. - November 23, 2021) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company"), is …See details»
Advanced Proteome Therapeutics Provides Update on Covid …
Aug 24, 2021 Burnaby, British Columbia / August 24, 2021 – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), reports that its US …See details»
Research programme: radioimmunoconjugates - Advanced …
If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with username/password or try to …See details»
Organization of the Proteostasis Network of Membraneless …
2 days ago To continue the study of the organization of the PN of MLOs, we analyzed the PN classes, which are the level below the PN branch in the taxonomy scheme of the PN. [8, 9] For …See details»